Citations & abstracts
The paper trail for the claims on this site. Form, absorption, and “it failed the big trial” belong next to the actual papers — not next to a celebrity bottle. GAIT (pain paper) is Clegg, N Engl J Med 2006; structure follow-ups are Sawitzke 2008/2010.
1. The trial that joint-aisle marketing still tries to outrun
Clegg DO, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006;354:795–808.
Finding: 1,583 adults. Glucosamine HCl 1500 mg, chondroitin sulfate 1200 mg, both, celecoxib, or placebo for 24 weeks. In the overall group, glucosamine and chondroitin — alone or together — did not reduce pain effectively versus placebo. Celecoxib did. An exploratory subgroup with moderate-to-severe pain looked better on the combination; that was not the primary result.
On-site line: GAIT used glucosamine hydrochloride, not glucosamine sulfate 2KCl. That is why this site will not let a label that says only “glucosamine” slide.
PMID:16495392
Sawitzke AD, et al. The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial. Arthritis Rheum. 2008;58:3183–3191.
Finding: Two-year GAIT ancillary study on joint-space width. No statistically significant structural win for glucosamine, chondroitin, or the combination versus placebo in the overall analysis.
PMID:18821708
2. Form is not a marketing adjective
Setnikar I, Rovati LC. Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review. Arzneimittelforschung. 2001;51:699–725.
Finding: After oral crystalline glucosamine sulfate traced with 14C, fecal excretion over 120 h was 11.3% of the dose — at least 88.7% left the gut. Absolute oral bioavailability on globulin-incorporated radioactivity was about 44% after first-pass. Free glucosamine in plasma was often below older assay limits.
On-site line: The “close to 90% absorbed” figure on this site is the gastrointestinal-disappearance number from this line of work — not “90% parked in the knee in 30 minutes.” Use it as absorption-from-the-gut, then read the first-pass caveat.
PMID:11642003
Setnikar I, Palumbo R, Canali S, Zanolo G. Pharmacokinetics of glucosamine in man. Arzneimittelforschung. 1993;43:1109–1113.
Finding: Oral 14C-glucosamine sulfate: a proportion close to 90% absorbed; free glucosamine not detectable in plasma with that method; radioactivity later in plasma proteins; oral AUC about 26% of IV (first pass).
PMID:8267678
Chomchareon T, et al. Bioequivalence study of 500 mg glucosamine sulfate in Thai healthy volunteers. J Med Assoc Thai. 2009;92:1040–1047.
Finding: Glucosamine sulfate KCl vs NaCl, 500 mg, 24 healthy adults. Cmax and AUC ratios inside 80–125%. 2KCl and NaCl salts were bioequivalent for rate and extent of absorption.
On-site line: The site’s preference for the potassium salt is a formulation / sodium-load choice, not a claim that NaCl “does not work.” Both sulfate salts get in. HCl is the form GAIT actually tested.
PMID:19772185
Wangroongsub Y, et al. Comparable clinical outcomes between glucosamine sulfate-potassium chloride and glucosamine sulfate sodium chloride in mild and moderate knee osteoarthritis. J Med Assoc Thai. 2010.
Finding: Short-term RCT: GS-K 1500 mg vs GS-Na 1500 mg — similar WOMAC/SF-36 change; potassium rose more in the KCl arm but stayed in range.
PMID:20649060
3. Chondroitin is a different-sized object
Jackson CG, et al. The human pharmacokinetics of oral ingestion of glucosamine and chondroitin sulfate taken separately or in combination. Osteoarthritis Cartilage. 2010;18:297–302.
Finding: No evidence that ingested chondroitin sulfate appeared in the circulation under the regimens tested. Combining CS with glucosamine reduced glucosamine Cmax and AUC versus glucosamine alone.
On-site line: A large GAG in the capsule is not automatically a GAG in the joint space. Pain stories after CS, if real, may not be “the molecule parked itself in cartilage.”
PMID:19836414 · PMC2826597
4. Oral hyaluronic acid is not an injection in a capsule
Šimek M, et al. Molecular weight and gut microbiota determine the bioavailability of orally administered hyaluronic acid. Carbohydr Polym. 2023.
Finding: 13C-HA in mice. Gut microbes (Bacteroides) chop HA to small oligosaccharides; some absorb; the rest become short-chain fatty acids. Oral bioavailability about 0.2%. Authors say distal effects (skin, joint) are unlikely to be intact HA arriving at the site.
On-site line: “Most of the oral HA never shows up as HA in the joint” is the conservative reading. The site’s “over 90% in the poop in 24 hours” is stronger than this paper; this paper says most of the carbon is metabolized, not delivered as polymer to cartilage. Do not over-claim fecal recovery unless you have that assay.
PMID:37182970
Kimura M, et al. Absorption of orally administered hyaluronan. J Med Food. 2016;19:1172–1179.
Finding: Oral HA degraded by cecal content, not by gastric/intestinal juice alone; oligosaccharides can cross large-intestine sacs; labeled pieces later found in rat skin. Mechanism is breakdown-then-absorb, not intact polymer transit.
PMID:27982756
5. Herbs in a daily joint bottle are still drugs
Devil’s claw, yucca, boswellia, and “herbal flex” blends belong on HerbsAreDrugs and in LiverTox / interaction lists — not in a product you take every morning for years because a label said “joint support.”
The site’s older line that daily yucca makes joints “age much quicker” is a strong claim. A 2023 feedlot paper on Yucca schidigera extract in cattle is about rumen fermentation, not cartilage aging. Until a primary joint-histology paper is on this page, treat that sentence as a caution to investigate — not as a numbered result.
HerbsAreDrugs research file · LiverTox · Ang-Lee JAMA 2001 perioperative herbs PMID:11448272
6. Sulfate-form structure trials (not GAIT’s HCl)
Reginster JY, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet. 2001;357:251–256.
Finding: 212 people with knee OA, 3 years, 1,500 mg glucosamine sulphate vs placebo. Mean joint-space loss was smaller on sulphate (−0.06 mm) than placebo (−0.31 mm). WOMAC improved on sulphate.
PMID:11214126
Pavelka K, et al. Glucosamine sulfate use and delay of progression of knee osteoarthritis. Arch Intern Med. 2002;162:2113–2123.
Finding: 202 people, 3 years, crystalline glucosamine sulphate. Less severe joint-space narrowing than placebo.
PMID:12374520
Herrero-Beaumont G, et al. Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator (GUIDE). Arthritis Rheum. 2007;56:555–567.
Finding: Crystalline glucosamine sulphate 1,500 mg once daily beat placebo on Lequesne index; acetaminophen as side comparator did not.
PMID:17265490
Meulyzer M, et al. Comparison of pharmacokinetics of glucosamine and synovial fluid levels following administration of glucosamine sulphate or glucosamine hydrochloride. Osteoarthritis Cartilage. 2008;16:973–979.
Finding: Horses, equivalent doses. Crystalline sulphate had higher median oral bioavailability than HCl (9.4% vs 6.1%) and delivered more glucosamine into synovial fluid.
On-site line: Form is not a slogan. Same sugar, different salt, different amount that shows up in the joint fluid in this veterinary PK work.
PMID:18295513
7. MSM is sulfur, not a painkiller herb
Kim LS, et al. Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial. Osteoarthritis Cartilage. 2006;14:286–294.
Finding: MSM 3 g/day, 12 weeks, modest pain/function change vs placebo in a small trial.
PMID:16309928
Debbi EM, et al. Efficacy of methylsulfonylmethane supplementation on osteoarthritis of the knee: a randomized controlled study. BMC Complement Altern Med. 2011;11:50.
Finding: 3.375 g/day MSM, 12 weeks — modest WOMAC improvements vs placebo.
PMID:21708034
8. MD's Choice article library (same company, same argument)
The long Joints Report is one cut of a larger free library. Those pages keep historic abstracts plus later-study notes. Use them as reading rooms, then come back here for the PubMed links.
9. What a company still has to do
Dietary-supplement GMPs: identity, purity, strength, composition. No premarket proof that the capsule rebuilds a knee. 21 CFR 111 · FDA 101
Article PDF: joints-report-article.pdf